Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome

BACKGROUND: Aortic-root dissection is the leading cause of death in Marfan's syndrome. Studies suggest that with regard to slowing aortic-root enlargement, losartan may be more effective than beta-blockers, the current standard therapy in most centers. METHODS: We conducted a randomized trial c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:N Engl J Med
Auteurs principaux: Lacro, R.V., Dietz, H.C., Sleeper, L.A., Yetman, A.T., Bradley, T.J., Colan, S.D., Pearson, G.D., Tierney, E.S. Selamet, Levine, J.C., Atz, A.M., Benson, D.W., Braverman, A.C., Chen, S., De Backer, J., Gelb, B.D., Grossfeld, P.D., Klein, G.L., Lai, W.W., Liou, A., Loeys, B.L., Markham, L.W., Olson, A.K., Paridon, S.M., Pemberton, V.L., Pierpont, M.E., Pyeritz, R.E., Radojewski, E., Roman, M.J., Sharkey, A.M., Stylianou, M.P., Wechsler, S. Burns, Young, L.T., Mahony, L.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4386623/
https://ncbi.nlm.nih.gov/pubmed/25405392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1404731
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires